mRNA |
SZ4TA2 |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.7 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
narciclasine |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
PF-4800567 hydrochloride |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.7 |
mRNA |
BRD-K04800985 |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
BRD-K84807411 |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.7 |
mRNA |
Gefitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
CD-1530 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
KH-CB19 |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.7 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |